eMedicine Specialties > Pediatrics: General Medicine > Gastroenterology
Alagille Syndrome: Differential Diagnoses & Workup
Updated: Oct 22, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Differential Diagnoses
| Biliary Atresia | Progressive Familial Intrahepatic
Cholestasis |
| Congenital Hepatic Fibrosis | Tyrosinemia |
| Cystic Fibrosis | |
| Jaundice, Neonatal | |
| Polycystic Kidney Disease |
Other Problems to Be Considered
Byler disease
Choledochal cyst
Inspissated bile syndrome
Workup
Laboratory Studies
- Evaluate patients with Alagille syndrome (AS) for chronic liver disease, including parameters of function and differential diagnoses.
- Fat-soluble vitamin deficiencies are frequently observed in Alagille syndrome.
- Prolongation of prothrombin time (PT) or activated partial thromboplastin time (aPTT) is often observed and can be corrected with intravenous vitamin K supplementation followed by oral dosing.
- Several abnormalities of liver function commonly noted in patients with Alagille syndrome reflect chronic cholestasis.
- Hypercholesterolemia (>200 mg/dL) and hypertriglyceridemia (500-2000 mg/dL) are commonly present, reflective of underlying chronic cholestasis.
- Gamma-glutamyl transpeptidase (GGT) and alkaline phosphatase levels are generally elevated. If significant discrepancies are observed between the degree of elevation of GGT and alkaline phosphatase levels, consider the possibility of occult zinc deficiency or vitamin D deficiency.
- The total bilirubin level during infancy is generally 4-14 mg/dL with a direct fraction generally greater than 30% of total bilirubin. In most children, elevation of bilirubin levels resolve after the first year of life.
- Serum bile acids are significantly elevated with increased amounts of cholic and chenodeoxycholic acids.
- In older patients with long-standing Alagille syndrome, monitor renal function and screen for hepatocellular carcinoma at routine intervals.
- Suspect vitamin E deficiency in the presence of mild hemolytic anemia and diminished deep tendon reflexes or ataxia.
- Assay the adequacy of vitamin A and D stores via measurement of levels (25-OH vitamin D and vitamin A).
- In infants with cholestatic liver disease, exclude other diagnoses including cystic fibrosis (sweat chlorine or cystic fibrosis DNA testing), hypothyroidism (thyroid functions), galactosemia (urine-reducing substance), sepsis or infection (urinary tract infection or cytomegalovirus), and alpha-1 antitrypsin deficiency (serum alpha-1 antitrypsin level with PI typing).
- Less common considerations include inborn errors of bile acid metabolism (urine for bile acids) and progressive familial intrahepatic cholestasis.
- Chromosomal analysis for mutations within the JAG1 gene (20p12) confirms diagnosis of Alagille syndrome. DNA sequencing is required for confirmation of diagnosis in most patients with Alagille syndrome because only 6-7% have complete deletion of the JAG1 gene.
Imaging Studies
- Diagnostic testing is important to exclude other causes of cholestasis and to evaluate for associated malformations.
- Abdominal ultrasonography screens for renal anomalies and grossly evaluates the hepatobiliary tree and the hepatic parenchyma.
- Further delineation of biliary anatomy may be required. This may be obtained using studies including dimethyl iminodiacetic acid (HIDA) scanning, magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography (ERCP) (selected centers), or intraoperative cholangiography.
- Conduct routine ultrasonography in older patients to screen for hepatoma or hepatocellular carcinoma.
- Associated anomalies (eg, vertebral anomalies) may be screened via spine films.
Other Tests
- Patients may require an ECG to exclude the presence of Wolff-Parkinson-White or hemodynamically significant, right-sided cardiac malformations from the diagnosis.
- An ophthalmologic assessment screens for anomalies including posterior embryotoxon, Axenfeld anomaly, and retinal changes.
Procedures
- A liver biopsy is suggested to evaluate architecture and histology.
- An ERCP or cholangiography evaluates biliary anatomy and excludes choledochal cysts and inspissated bile syndrome from the diagnosis.
Histologic Findings
- Liver biopsy specimens typically exhibit features suggestive of chronic cholestasis and paucity of interlobular bile ducts.
- Most biopsy findings (wedge or needle) reveal features of bile duct paucity; typically, biopsy findings reveal interlobular bile ducts-to-portal ratio of less than 0.4 in 10 portal tracts. However, biopsy findings during the neonatal period may exhibit ballooning and giant cell transformation of hepatocytes.
- Bile duct proliferation in biopsy samples of young infants has rarely been reported.
More on Alagille Syndrome |
| Overview: Alagille Syndrome |
 Differential Diagnoses & Workup: Alagille Syndrome |
| Treatment & Medication: Alagille Syndrome |
| Follow-up: Alagille Syndrome |
| Multimedia: Alagille Syndrome |
| References |
| « Previous Page | Next Page » |
References
Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome. J Med Genet. Feb 1997;34(2):152-7. [Medline].
Watson GH, Miller V. Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child. Jun 1973;48(6):459-66. [Medline].
Alagille D, Odievre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr. Jan 1975;86(1):63-71. [Medline].
McDaniell R, Warthen DM, Sanchez-Lara PA, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet. Jul 2006;79(1):169-73. [Medline].
Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. Jul 1997;16(3):243-51. [Medline].
Krantz ID, Colliton RP, Genin A, et al. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet. Jun 1998;62(6):1361-9. [Medline].
Bucuvalas JC, Horn JA, Carlsson L, et al. Growth hormone insensitivity associated with elevated circulating growth hormone-binding protein in children with Alagille syndrome and short stature. J Clin Endocrinol Metab. Jun 1993;76(6):1477-82. [Medline].
Hingorani M, Nischal KK, Davies A, et al. Ocular abnormalities in Alagille syndrome. Ophthalmology. Feb 1999;106(2):330-7. [Medline].
Emerick KM, Rand EB, Goldmuntz E, et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. Mar 1999;29(3):822-9. [Medline].
Lalani SR, Thakuria JV, Cox GF, Wang X, Bi W, Bray MS. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet. Mar 2009;46(3):168-75. [Medline].
Kamath BM, Spinner NB, Emmerich KM, et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004;110:1354-8. [Medline]. [Full Text].
Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. Apr 1990;98(4):1013-6. [Medline].
Kasahara M, Kiuchi T, Inomata Y, et al. Living-related liver transplantation for Alagille syndrome. Transplantation. Jun 27 2003;75(12):2147-50. [Medline].
Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology. Jul 1988;95(1):130-6. [Medline].
[Guideline] Murray KF, Carithers RL Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. Jun 2005;41(6):1407-32. [Medline]. [Full Text].
Bekassy AN, Garwicz S, Wiebe T, et al. Hepatocellular carcinoma associated with arteriohepatic dysplasia in a 4-year-old girl. Med Pediatr Oncol. 1992;20(1):78-83. [Medline].
Danks DM, Campbell PE, Jack I, et al. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child. May 1977;52(5):360-7. [Medline].
Gottrand F, Clavey V, Fruchart JC, Farriaux JP. Lipoprotein pattern and plasma lecithin cholesterol acyl transferase activity in children with Alagille syndrome. Atherosclerosis. Jun 1995;115(2):233-41. [Medline].
Hoffenberg EJ, Narkewicz MR, Sondheimer JM, et al. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr. Aug 1995;127(2):220-4. [Medline].
Kay MH, Wyllie R, Steffen RM. Use of ursodeoxycholic acid in the treatment of arteriohepatic dysplasia. Clin Pediatr (Phila). Nov 1996;35(11):593-6. [Medline].
Martin SR, Garel L, Alvarez F. Alagille's syndrome associated with cystic renal disease. Arch Dis Child. Mar 1996;74(3):232-5. [Medline].
Miguet JP, Mavier P, Soussy CJ, Dhumeaux D. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterology. May 1977;72(5 Pt 1):924-6. [Medline].
Oestreich AE, Sokol RJ, Suchy FJ, Heubi JE. Renal abnormalities in arteriohepatic dysplasia and nonsyndromic intrahepatic biliary hypoplasia. Ann Radiol (Paris). Feb-Mar 1983;26(2-3):203-9. [Medline].
Quiros-Tejeira RE, Ament ME, Heyman MB, et al. Variable morbidity in alagille syndrome: a review of 43 cases. J Pediatr Gastroenterol Nutr. Oct 1999;29(4):431-7. [Medline].
Rabinovitz M, Imperial JC, Schade RR, Van Thiel DH. Hepatocellular carcinoma in Alagille's syndrome: a family study. J Pediatr Gastroenterol Nutr. Jan 1989;8(1):26-30. [Medline].
Russo PA, Ellis D, Hashida Y. Renal histopathology in Alagille's syndrome. Pediatr Pathol. 1987;7(5-6):557-68. [Medline].
Shulman SA, Hyams JS, Gunta R. Arteriohepatic dysplasia (Alagille syndrome): extreme variability among affected family members. Am J Med Genet. Oct 1984;19(2):325-32. [Medline].
Further Reading
Keywords
Alagille syndrome, AS, Alagille's syndrome, Alagille-Watson syndrome, arteriohepatic dysplasia, syndromic bile duct paucity, pulmonary valvular stenosis, hypoplasia of the hepatic ducts, mental retardation, treatment, diagnosis
